European equities traded in the US as American depositary receipts were on the rise late Thursday morning, increasing 0.82% to 1,663.66 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and biopharmaceutical firm Cellectis (CLLS), which rose 4.6% and 3.9%, respectively. They were followed by telecommunications company Nokia (NOK) and pharmaceutical firm Novo Nordisk (NVO), which advanced 3.6% and 2.6% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and medical device maker EDAP TMS (EDAP), which fell 3.8% and 1.7% respectively. They were followed by oil and gas company Eni (E) and petroleum refiner Equinor (EQNR), which were off 0.2% each.

From the UK and Ireland, the gainers were led by cruise line operator Carnival (CUK) and biopharmaceutical company Akari Therapeutics (AKTX), which increased 4% and 3.4% respectively. They were followed by communications company WPP (WPP) and alcoholic beverage company Diageo (DEO), which were up 3% each.

The decliners from the UK and Ireland were led by biopharmaceutical firms Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which dropped 8.7% and 3%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and medical device manufacturer Smith & Nephew (SNN), which lost 1.9% and 1.7% respectively.